Skip to content

Clinical trials

Major Depressive Disorder trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: Russia Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20055
20063
20074
20086
20094
20104
20115
20124
20131
20141
20152
20164
20172
20182
20191
20205
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S8
Eli Lilly and Company7
Janssen Research & Development, LLC7
Sanofi6
GlaxoSmithKline4
Takeda4
AstraZeneca3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Hoffmann-La Roche2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder56
Depressive Disorder11
Mood Disorders7
Mental Disorders5
Anxiety Disorders2
Psychomotor Disorders2
Bipolar Disorder1
Dysthymic Disorder1
Lethargy1
Migraine Disorders1

Trials

Showing 76 to 56 of 56. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.